Timothy Alexander

Solana Company Moves to Tokenize HSDT Shares in Bid to Reshape Market Access NEWTOWN, PA — Solana Company (NASDAQ: HSDT) unveiled plans to tokenize shares of its HSDT fund on Superstate’s Opening Bell platform, marking a sig […]

Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) reported third-quarter 2025 financial results and detailed a series of clinical, operational, and i […]

Prelude Advances Two Novel Cancer Programs as Cash Runway Extends Into 2027 WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) reported third-quarter 2025 financial results and outlined key progress across its o […]

China Clears IND for SEED Therapeutics’ First-in-Class Cancer Drug in Global Trial Push KING OF PRUSSIA, PA — SEED Therapeutics announced that China’s National Medical Products Administration has cleared the Investigational New Drug app […]

Hydrogel Innovator NEXGEL Posts Steady Q3 as Margin Gains Offset Flat Revenue LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) reported third quarter 2025 results showing stable revenue and improved margins as the hydrogel m […]

Pennsylvania’s Sharp Shopper Ranks Among Top U.S. Destinations for Low-Cost Thanksgiving Groceries PENNSYLVANIA — As Thanksgiving approaches and grocery bills continue to strain household budgets, a new national survey has identified the c […]

Weitz Firm Expands Injury Services as Slip-and-Fall Claims Surge in North Philadelphia PHILADELPHIA, PA — The Weitz Firm, LLC announced an expansion of its personal injury services into North Philadelphia and Brewerytown, a move d […]

Winterfest Returns With Big Brewers and Bigger Expectations for 2026 KENNETT SQUARE, PA — One of the region’s most celebrated craft beer traditions is gearing up for a milestone year as Kennett Winterfest prepares to ret […]

AI Engine Promises Buyer Activation in Weeks — pharosIQ Pushes B2B Marketing Forward PHILADELPHIA, PA — pharosIQ unveiled a major upgrade to its atlasIQ Intelligence Engine, positioning the platform as a high-speed activation tool d […]

Chester County Dojang Shines in High-Stakes New York Taekwondo Championship CHESTER SPRINGS, PA — Master Son’s Eagle Taekwondo has earned national recognition after delivering a standout performance at the 37th New York Sta […]

Palvella Races Toward Key 2026 Readouts as Rare-Disease Pipeline Expands Rapidly WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) reported third-quarter results and detailed an intensifying slate of clinical milestones as i […]

Passage Bio Pushes Toward Key 2026 Milestones as Gene Therapy Program Accelerates PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) reported third-quarter financial results and outlined steady progress across its upliFT-D gene t […]

Orchestra BioMed’s Big Cash Infusion Sets Stage for High-Stakes Cardiology Trials NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) reported third-quarter financial results and detailed a series of strategic and r […]

Philly’s Best Unveils Bold Rebrand as It Prepares for Major Expansion YEADON, PA — Philly’s Best Steak Company is stepping into its next chapter with a sharp new brand identity, renewed messaging, and ambitious exp […]

Mineralys Nears Pivotal FDA Filing as Hypertension Drug Lorundrostat Advances RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported third-quarter financial results and said it is preparing to submit a New Drug A […]

New CAR-T Data Could Upend T-Cell Lymphoma Care — Vittoria Prepares First Reveal PHILADELPHIA, PA — Vittoria Biotherapeutics, Inc. announced it will present interim clinical data from its first-in-human Phase 1 study of VIPER-101, a […]

ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported third-quarter financial results and outlined major clinical milestones that p […]

New Cancer Data Hints at a Surgery-Free Future — Verrica’s VP-315 Shows Big Promise WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) unveiled compelling new data from its Phase 2 study of VP-315, a first-in-class o […]

AstraZeneca’s Fasenra Shows Major Breakthrough in Delaying HES Disease Flares WILMINGTON, DE — AstraZeneca reported statistically significant Phase III results showing that Fasenra (benralizumab) can substantially delay disease w […]

Chemours Posts Solid Q3 as Refrigerants Surge and Other Segments Struggle WILMINGTON, DE — The Chemours Company delivered a mixed third quarter, with strong refrigerant demand helping offset weakness across its titanium d […]